Male Infertility Diagnosis and Treatment Market Size & Growth Analysis Report, 2022

The global male infertility diagnosis and treatment market is estimated to grow at a CAGR of more than 4% during the forecast period. Due to the rising incidences of male infertility, there are various developments taking place to provide an effective and reliable solution to overcome this problem. For instance, in May 2019, Aytu BioScience, Inc. declared the availability of MiOXSYS in UK. It is the company’s seminal oxidative stress test for male infertility assessment. Oxidative stress is one of the major causes of male infertility and has negative effects on spermatozoa. It is a major cause of sperm dysfunctioning and DNA damage. MiOXSYS is an advanced in vitro diagnostic test that evaluates seminal oxidative stress. It acts as an influential marker of sperm function. This test will enable UK physicians to conduct effective assessment and monitoring of male infertility patients.

Request a Free Sample of our Male Infertility Diagnosis and Treatment Market :  https://www.omrglobal.com/request-sample/male-infertility-market

Furthermore, in August 2019, Brooklyn-based Dadi, a startup that offers at-home male fertility test and sperm storage kit, raised $5 million in investment funding. This new funding will enable the company to leverage its customer service capabilities. In addition, with the availability of funding, the company will actively work for the development of new technology for male infertility. Such kinds of developments and funding opportunities are anticipated to increase the reliability and accuracy of male infertility diagnostic tests and would offer considerable opportunity for the growth of the global male infertility diagnosis and treatment market. 

The most common diagnostic tests used for male infertility include semen analysis, urinalysis, genetic testing, testicular biopsy and hormonal tests. Semen analysis is the most commonly used test for the evaluation of male infertility. It measures the amount and quality of the fluid released during ejaculation. It assesses the liquid portion referred to as semen or seminal fluid. A normal semen analysis measures sperm count, motility and concentration, semen volume, pH and number or percent of normal and abnormal (defective) sperm in terms of size and shape (morphology).
North America is showing potential growth in the global male infertility market. The factors contributing to the growth of the market in the region include significant awareness for infertility diagnosis and treatment and emerging demand for assisted reproductive technology (ART) in the region. Asia-Pacific region is expected to show a rapid growth in the market owing to rising infertility rates and unhealthy lifestyle factors. A significant rise in infertility clinics has been witnessed in the region. For instance, as per National Institute of Health & Family Welfare (NIHFW), in 2017, there were more than 20,000 ART clinics in India providing IVF and IUI (intrauterine insemination) services, merely 1,500 clinics have applied for registration with Indian Council of Medical Research (ICMR).
The key players of the global male infertility diagnosis and treatment market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB and Medical Electronic Systems. Mergers and acquisitions, product launches and geographical expansion are the major strategies adopted by the major players to expand market share. For instance, in January 2017, PerkinElmer, Inc. acquired Tulip Diagnostics Pvt. Ltd., a provider of in-vitro diagnostic reagents, instruments and kits to a wide customer base of diagnostic labs, government and private healthcare facilities. This will enable the firm to set up its diagnostics business and further position its long-term growth in the emerging diagnostics market.

A full Report of Male Infertility Diagnosis and Treatment Market is Available at:  https://www.omrglobal.com/industry-reports/male-infertility-market

Global Male Infertility Diagnosis and Treatment Market Segmentation 

By Diagnostic Tests

Semen Analysis
Urinalysis
Genetic Testing
Testicular Biopsy
Hormonal Tests
Others (Anti-sperm Antibodies Test and Ultrasound)

By Treatment

Drugs
ART Therapy
Surgery

Global Male Infertility Diagnosis and Treatment Market Segmentation by region

North America

US
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
COMPANY PROFILES
ACCESS PHARMACEUTICALS, INC.
INTRODUCTION
ACCESS PHARMACEUTICALS, INC. PRODUCT PORTFOLIO
ACCESS PHARMACEUTICALS, INC. RECENT ACTIVITIES
ANDROLOGY SOLUTIONS
INTRODUCTION
ANDROLOGY SOLUTIONS PRODUCT PORTFOLIO
ANDROLOGY SOLUTIONS RECENT ACTIVITIES
ASKA PHARMACEUTICALS, INC.
INTRODUCTION
ASKA PHARMACEUTICALS, INC. PRODUCT PORTFOLIO
 ASKA PHARMACEUTICALS, INC. RECENT ACTIVITIES
 BAYER AG
INTRODUCTION
BAYER AG PRODUCT PORTFOLIO
 BAYER AG RECENT ACTIVITIES
BRISTOL-MAYERS SQUIBB CO.
INTRODUCTION
 BRISTOL-MAYERS SQUIBB CO.. PRODUCT PORTFOLIO
 BRISTOL-MAYERS SQUIBB CO.RECENT ACTIVITIES
 CADILA HEALTHCARE LTD.
 INTRODUCTION
CADILA HEALTHCARE LTD. PRODUCT PORTFOLIO
 CADILA HEALTHCARE LTD. RECENT ACTIVITIES
CHURCH & DWIGHT COMPANY INC. 
INTRODUCTION
 CHURCH & DWIGHT COMPANY INC.  PRODUCT PORTFOLIO
CHURCH & DWIGHT COMPANY INC.  RECENT ACTIVITIES
 COOK MEDICAL INC.
 INTRODUCTION
 COOK MEDICAL INC. PRODUCT PORTFOLIO
COOK MEDICAL INC. RECENT ACTIVITIES
COOPER SURGICAL INC.
INTRODUCTION
COOPER SURGICAL INC. PRODUCT PORTFOLIO
COOPER SURGICAL INC. RECENT ACTIVITIES
CORDEX PHARMA, INC.
INTRODUCTION
CORDEX PHARMA, INC. PRODUCT PORTFOLIO
CORDEX PHARMA, INC. RECENT ACTIVITIES
ELI LILLY & CO.
INTRODUCTION
ELI LILLY & CO. PRODUCT PORTFOLIO
ELI LILLY & CO. RECENT ACTIVITIES
EMD SERONO, INC.
INTRODUCTION
EMD SERONO, INC. PRODUCT PORTFOLIO
EMD SERONO, INC. RECENT ACTIVITIES
ENDO PHARMACEUTICALS
INTRODUCTION
ENDO PHARMACEUTICALS PRODUCT PORTFOLIO
ENDO PHARMACEUTICALS RECENT ACTIVITIES
HALOTECH DNA SL
INTRODUCTION
HALOTECH DNA SL PRODUCT PORTFOLIO
HALOTECH DNA SL RECENT ACTIVITIES
INTAS PHARMACEUTICALS.
INTRODUCTION
INTAS PHARMACEUTICALS PRODUCT PORTFOLIO
INTAS PHARMACEUTICALS RECENT ACTIVITIES
IRAVINE SCIENTIFIC
INTRODUCTION
IRAVINE SCIENTIFIC PRODUCT PORTFOLIO
IRAVINE SCIENTIFIC RECENT ACTIVITIES
MERCK SERONO INC.
INTRODUCTION
MERCK SERONO INC. PRODUCT PORTFOLIO
MERCK SERONO INC. RECENT ACTIVITIES
MICROM UK LTD.
INTRODUCTION
MICROM UK LTD. PRODUCT PORTFOLIO
MICROM UK LTD. RECENT ACTIVITIES
PANTARHEI BIOSCIENCE B.V.
INTRODUCTION
PANTARHEI BIOSCIENCE B.V.  PRODUCT PORTFOLIO
PANTARHEI BIOSCIENCE B.V.  RECENT ACTIVITIES
PARALLABS
INTRODUCTION
PARALLABS PRODUCT PORTFOLIO
PARALLABS RECENT ACTIVITIES

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/male-infertility-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.